Ovata Capital Management LTD Freeline Therapeutics Holdings PLC Transaction History

Ovata Capital Management LTD

  • $86.9 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$12.3 - $18.2 $184,266 - $272,654
-14,981 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$14.94 - $18.3 $336,433 - $412,097
-22,519 Reduced 60.05%
14,981 $274,000
Q3 2020

Nov 13, 2020
BUY
$15.45 - $18.12 $579,375 - $679,500
37,500 New
37,500 $585,000

Others Institutions Holding FRLN

# of Institutions
1
Shares Held
30.1K
Call Options Held
0
Put Options Held
0
View Full List

About Freeline Therapeutics Holdings plc

FRLN Quotes by TradingView
  • Ticker FRLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,972,300
  • Description
  • Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its advanced product candidate is verbrinacogene setparvovec (FLT180a), a gene therapy product candidate that is in P...
More about FRLN
Track This Portfolio

Track Ovata Capital Management LTD Portfolio

Follow Ovata Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ovata Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ovata Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email